×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Clinical: UPenn Observational Research Repository (NCT04715399)
clinical
1,506 words
KG: UPenn Observational Research Repository (NCT04715399)
2026-03-27
kind:clinical-trial
section:clinical-trials
state:published
biobank
repository
longitudinal
neurodegeneration
biomarkers
genetics
neuroimaging
Contents
UPenn Observational Research Repository (NCT04715399)
Knowledge Graph
Related Hypotheses (24)
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49
APOE Isoform Expression Across Glial Subtypes
Score: 0.48
Cryptic Exon Silencing Restoration
Score: 0.46
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46
Cross-Seeding Prevention Strategy
Score: 0.45
APOE Isoform Conversion Therapy
Score: 0.44
Glycine-Rich Domain Competitive Inhibition
Score: 0.43
RNA-Binding Competition Therapy for TDP-43 Cross-Seeding
Score: 0.37
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68
Prime Editing Precision Correction of APOE4 to APOE3 in Micr
Score: 0.62
Microglial AIM2 Inflammasome as the Primary Driver of TDP-43
Score: 0.60
Smartphone-Detected Motor Variability Correction
Score: 0.56
Glymphatic-Mediated Tau Clearance Dysfunction
Score: 0.55
Multiplexed Base Editing for Simultaneous Neuroprotective Ge
Score: 0.53
Dual-Circuit Tau Vulnerability Cascade
Score: 0.50
Dopaminergic Ventral Tegmental-Hippocampal Circuit Protectio
Score: 0.49
Acid-Degradable LNP-Mediated Prenatal CRISPR Intervention fo
Score: 0.47
Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.45
Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.44
Show 19 more
Related Analyses (29)
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · failed
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · archived
Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed
Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived
Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived
Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · failed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived
Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed
TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · completed
GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed
Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Show 24 more
Related Experiments (15)
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Longitudinal TLR2 reporter gene study in α-synuclein mice
validation · proposed · Score: 0.90
Tau depletion effects on neuronal development in primary cul
exploratory · proposed · Score: 0.90
Dexamethasone treatment study in α-synuclein mice
validation · proposed · Score: 0.85
Microtubule domain analysis in adult axons
exploratory · proposed · Score: 0.80
TLR expression in α-synuclein overexpressing mice
validation · proposed · Score: 0.80
s:** - Single-cell RNA-seq to measure editing efficiency acr
falsification · proposed · Score: 0.40
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40
ALS Regional Onset and Spread: Network-Level Staging Model
clinical · proposed · Score: 0.40
Environmental Exposure Causal Attribution in ALS — Experimen
validation · proposed · Score: 0.40
Pre-Symptomatic Tau Detection in MAPT Mutation Carriers
clinical · proposed · Score: 0.40
Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40
FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation
clinical · proposed · Score: 0.40
Show 10 more
See Also (15)
vitamin-d-therapy-neurodegeneration
therapeutic · Pages share 11 hypotheses
TREM2 Agonist Therapy for Neurodegeneration
therapeutic · Pages share 11 hypotheses
Trace Amine-Associated Receptor (TAAR) Modulator Therap
therapeutic · Pages share 11 hypotheses
SYK Kinase Inhibitor Therapy for Neurodegeneration
therapeutic · Pages share 11 hypotheses
STING Inhibitor Therapy in Neurodegeneration
therapeutic · Pages share 11 hypotheses
Specialized Pro-Resolving Mediator (SPM) Therapy for Ne
therapeutic · Pages share 11 hypotheses
Specialized Pro-Resolving Mediator (SPM) Therapies for
therapeutic · Pages share 11 hypotheses
Somatostatin Receptor Modulator Therapy in Neurodegener
therapeutic · Pages share 11 hypotheses
S100 Protein (S100A8/A9/A12) Modulator Therapy for Neur
therapeutic · Pages share 11 hypotheses
RNA Targeting Therapy for Neurodegeneration
therapeutic · Pages share 11 hypotheses
Progranulin Therapy for Neurodegeneration
therapeutic · Pages share 11 hypotheses
nt-3-therapy-neurodegeneration
therapeutic · Pages share 11 hypotheses
Neurotensin Receptor Modulator Therapy for Neurodegener
therapeutic · Pages share 11 hypotheses
Nanoparticle Drug Delivery for Neurodegeneration
therapeutic · Pages share 10 hypotheses
N-Acetylcysteine Therapy for Neurodegeneration
therapeutic · Pages share 11 hypotheses
Show 10 more
Knowledge Graph (5 edges)
UPenn Observational Research Repository (NCT04715399)
references
SST
UPenn Observational Research Repository (NCT04715399)
references
APOE
UPenn Observational Research Repository (NCT04715399)
references
VCP
UPenn Observational Research Repository (NCT04715399)
references
SNCA
UPenn Observational Research Repository (NCT04715399)
references
TARDBP